MIP Discovery secures £7m investment to revolutionize cell and gene therapy manufacturing with synthetic antibody alternatives, paving the way for widespread adoption of life-changing medicines. Read more
Investments By Sector
Calculus Capital has invested in these sectors
Energy
50.0%
Biotech
50.0%
Venture Capital Investors
Connect with VC Investors from Calculus Capital
They Have Invested With Calculus Capital
Connect with investors related to Calculus Capital's network